Literature DB >> 18716185

Strategies for atopy prevention.

H Ulrich Wahn1.   

Abstract

Allergic diseases, particularly in childhood, have become one of the epidemics of the 21st century. Whereas previous strategies for allergy prevention focused on the avoidance of risk factors, more recent approaches are addressing attempts to provide protective factors to infants and young children to achieve immune modulation and tolerance to harmless nutritional or environmental allergens. This change of paradigm for allergy prevention might lead to more effective interventions, which hopefully contribute to reversing the epidemiologic trend of the last decades. In many industrialized countries, the increased prevalence of atopy and asthma has become a serious public health issue. If preventive intervention could be effective at all, it would have to be applied early in life, most probably in early infancy. Unfortunately, our understanding of the natural history of the process of atopic sensitization, atopic dermatitis, and allergic airway disease is still very limited. On the other hand, the evaluation of risk factors and determinants is a necessary prerequisite for any effective intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716185     DOI: 10.1093/jn/138.9.1770S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  2 in total

1.  Omega-3 fatty acid supplementation during pregnancy and respiratory symptoms in children.

Authors:  María Consuelo Escamilla-Nuñez; Albino Barraza-Villarreal; Leticia Hernández-Cadena; Efraín Navarro-Olivos; Peter D Sly; Isabelle Romieu
Journal:  Chest       Date:  2014-08       Impact factor: 9.410

Review 2.  The Role of Prebiotics and Probiotics in Prevention of Allergic Diseases in Infants.

Authors:  Simona Sestito; Enza D'Auria; Maria Elisabetta Baldassarre; Silvia Salvatore; Valeria Tallarico; Ettore Stefanelli; Flora Tarsitano; Daniela Concolino; Licia Pensabene
Journal:  Front Pediatr       Date:  2020-12-22       Impact factor: 3.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.